XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS' EQUITY (Tables)
 3 Months Ended
Nov. 30, 2022
Equity [Abstract]  
Schedule of Shares Outstanding
Shares Outstanding

Shares of Company common stock outstanding for the three months ended November 30, 2022 and 2021 were as follows:
November 30,
20222021
Common stock outstanding, beginning of quarter20,260,070 20,141,521 
Common stock issued during the quarter53,685 27,275 
Common stock outstanding, end of quarter20,313,755 20,168,796 
Schedule of Dividends Payable
Dividends

The Company’s Board of Directors declared cash dividends during the fiscal years 2023 and 2021. The details of dividends paid are in the following tables:
(in thousands, except dividend per share)Fiscal Year 2023
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date		Dividend per
Share		Total Amount
10/31/202211/07/202220,299 $0.06 $1,218 
Total$1,218 
(in thousands, except dividend per share) Fiscal Year 2022
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date		Dividend per
Share		Total Amount
10/25/202111/01/202120,148 $0.06 $1,209 
1/31/20222/07/202220,178 $0.06 1,211 
4/25/20225/02/202220,207 $0.06 1,212 
7/25/20228/01/202220,239 $0.06 1,214 
Total  $4,846 
Share-based Payment Arrangement, Option, Activity
The following tables summarize information about stock options:
(in thousands, except per share and weighted-average amounts)
 Transactions during Three months ended November 30, 2022Number of
Options 		Weighted-Average
Exercise Price
Per Share		Weighted-Average
Remaining
Contractual Life
Outstanding, August 31, 20221,245 $28.61 6.14
Granted429 43.90 
Exercised(50)15.36 
Canceled/Forfeited(9)36.90 
Outstanding, November 30, 20221,615 $33.04 7.05
Vested and Exercisable, November 30, 2022716 $19.75 4.69
Vested and Expected to Vest, November 30, 20221,607 $32.99 7.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2023 and fiscal year 2022:
(in thousands, except prices)Three Months Ended November 30, 2022Fiscal Year 2022
Estimated fair value of awards granted$9,374 $4,597 
Unvested Forfeiture Rate0.00 %1.04 %
Weighted-average grant price$43.90 $42.13 
Weighted-average market price$43.90 $42.13 
Weighted-average volatility46.30 %42.80 %
Weighted-average risk-free rate4.33 %1.74 %
Weighted-average dividend yield0.55 %0.58 %
Weighted-average expected life6.59 years6.59 years
Share-based Payment Arrangement, Option, Exercise Price Range
The exercise prices for the options outstanding at November 30, 2022, ranged from $6.85 to $66.14, and the information relating to these options is as follows:
(in thousands except prices)
Exercise PriceAwards OutstandingAwards Exercisable
LowHighQuantityWeighted -Average
Remaining
Contractual
Life		Weighted-Average
Exercise
Price		QuantityWeighted-Average
Remaining
Contractual
Life		Weighted-Average
Exercise
Price
$6.85 $9.77 268 2.54 years$8.36 268 2.54 years$8.36 
$9.78 $18.76 184 4.24 years$10.10 184 4.24 years$10.10 
$18.77 $33.40 224 6.40 years$25.34 109 6.25 years$24.38 
$33.41 $47.63 651 9.39 years$42.08 84 7.84 years$37.92 
$47.64 $66.14 288 8.31 years$56.29 71 7.88 years$59.04 
  1,615 7.06 years$33.04 716 4.69 years$19.75